Neutral impactCorporate Action
Manipal Health IPO Day 3 Update: GMP remains at 1%, subscription at 45%. Should you Subscribe or Skip?
Economic Times 1 hr ago·31 Jul 2026, 2:29 am
The IPO for Manipal Health continues to progress steadily on its third day of subscription. The Grey Market Premium (GMP), which indicates the price investors are willing to pay in the unofficial market, has remained unchanged at 1%. This suggests the listing price is likely to be close to the issue price. Overall, the issue has received bids for approximately 45% of the total shares on offer, indicating moderate interest from investors.
The subscription status for the retail investor quota is also at 45%, with bids placed for 1.64 crore shares. This balanced response suggests that while there is demand, it is not overwhelming. For investors, this means the stock may list at a modest premium or at par. The key takeaway is that the issue is attracting a steady, but not exceptional, level of interest from the general public.
Key takeaways
- Category: Corporate Action.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
